Allogeneic bone marrow transplantation is the treatment of choice for several hematological conditions. Unfortunately, for the majority (70%) of patients an HLA-matched sibling donor is not available and a matched unrelated donor must be found if they are to proceed to allogeneic transplantation. Most of the donors on international registries are of Caucasian ethnic origin. It has been recognized that patients from certain racial groups have a reduced chance of finding an unrelated donor. This study reports the feasibility of finding an unrelated donor for our local New Zealand patients of Caucasian, New Zealand Maori and Pacific Islander ethnic origin presenting with transplantable hematological conditions at a single center. The search was performed on international registries using HLA-A,B and DR typings for our patients. Six of six and five of six matches were evaluated. We have shown that Maori and Pacific Islanders have significantly lower hit rates than Caucasians when searched for 6/6 antigen matches, but there was no significant difference between the three ethnic groups in finding a 5/6 antigen matched donor. This study supports the policy of the New Zealand Bone Marrow Donor Registry in recruiting New Zealand Maori and Pacific Islanders.
Allogeneic bone marrow transplantation is the treatment of choice for several hematological conditions. Unfortunately, for approximately 70% of patients an HLA-matched sibling donor is not available. 1 For these patients to proceed to allogeneic BMT a matched unrelated donor must be found. If no such donor is available, patient treatment options become limited to an autologous procedure or chemotherapy with possibly reduced cure rates.
The outcome of matched unrelated donor transplants is similar to those of ABMT but success of the former is highly dependent on close HLA identity of the recipient and donor. 2 Without close HLA matching the complication of GVHD and graft rejection is significant. In New Zealand (NZ) the majority of the population are Caucasian, but the indigenous people of this country, NZ Maori, constitute 14.5% of the total population. The NZ Pacific Island population constitutes 4.8% of the population. 5 This study reports the feasibility of finding a URD for our local NZ patients presenting with transplantable hematological conditions at a single center. We have used a similar approach to Beatty et al 6 by using this defined patient group in a simulated search of BMDW.
Patients and methods

Patients
This study is a retrospective analysis of patients presenting to the Hematology Division, Wellington Regional Oncology Unit, Wellington Hospital in New Zealand. The cohort included those presenting over a 10 year period (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) and meeting accepted criteria for allogeneic bone marrow transplantation.
Ethnic data
Determination of ethnicity of the study patients was obtained from self-reporting by patients on the hospital admission form which is the same methodology as is used by Statistics New Zealand for Census data collection. Population based data were obtained from Statistics New Zealand and The New Zealand Cancer Registry.
HLA typing
All study patients had HLA-A, -B and DR typing data available. All HLA typing was performed by standard serological methods.
Donor search
The virtual search was performed on the Bone Marrow Donors Worldwide database 7 through the New Zealand 
Statistics
Statistical significance of the results was analyzed using 2 analysis. Census figures for family size were analyzed using Wilcoxon rank sum test.
Results
A total of 153 patients were eligible for analysis. Of these 118 were Caucasians, 22 NZ Maori, and 13 Pacific Islanders. The hit rates of these patients finding a potential unrelated donor on the international registries are presented in Figure 1 . Results show that Caucasian patients have significantly higher chances of finding a six out of six antigen matched donor when compared to NZ Maori (P Ͻ 0.042) and Pacific Islander (P Ͻ 0.001) patients. However, no sig- It has been recognized that patients from certain racial groups have a reduced chance of finding an unrelated donor. 6 Whether NZ Maori and Pacific Island patients are similarly disadvantaged has been inferred but not known with certainty.
NZ Maori are indigenous people of New Zealand. They arrived in New Zealand approximately 800 years ago, probably from eastern Polynesia. Pacific Islanders are recent migrants to New Zealand (last 50 years) the majority being from the Polynesian islands of Samoa, Tonga, Tokelau, Niue, Cook Islands and Fiji. Ethnic composition of NZ is shown in Figure 2 . Genetic distances between NZ Maori and Pacific Islanders (Polynesians) and other world populations are shown in Figure 3 .
We have taken HLA typings from NZ patients eligible for BMT and searched the BMDW database for six out of six and five out of six HLA-A, -B, -DR matches. At the time of the search there were no NZ donors on the registry database. This study shows NZ Maori and Pacific Islanders are significantly less likely to find a potential donor than Caucasian patients for a six out of six match. The match rate of 80% for NZ Caucasians was similar to that found for American Caucasians on the NMDR. 6 These findings are consistent with the observation that certain HLA alleles are under-or overexpressed in the NZ Maori/Pacific Island population compared to Caucasians. Allele frequencies of NZ Maori and Pacific Islander patients in this study are concordant with allele frequencies for Polynesians reported in the literature [8] [9] [10] and with our recent study on DR types in NZ Maori 11 and they are different from Caucasians (higher frequencies of HLA-DR4, DR8, DR11, DR12, A2, A11, A24, B55, B60 and B61) producing lower hit rates for six out of six match for NZ Maori and Pacific Islanders because of the predominance of Caucasians on international registries.
Higher hit rates observed in NZ Maori patients compared to Pacific Islanders are attributed to a long history of intermarriage and admixture of NZ Maori and Caucasians. This admixture has been observed in HLA types in both NZ Maori and Caucasian patients. Pacific Islanders are histori- 14 cally recent migrants to New Zealand with less Caucasian admixture hence the lower hit rate. However, with DNAbased HLA data, the number of potential donors would be less than observed. Unfortunately not all of the DRB data on BMDW are DNA-based and none for the HLA-A, -B. The identification of a six out of six HLA-A, -B, -DR matched donor is the ideal for a matched unrelated transplant. If, however, a five out of six match is acceptable then the chances of finding a potential donor changes appreciably. Given this lower level of matching there was no significant difference between NZ Maori, Pacific Islanders or Caucasians in finding a donor. The clinical utility of these less rigorously matched transplants (with higher incidence of GVHD and graft rejection) is unclear. 12 Due to an inadequate HLA database we are not able to calculate haplotype frequency rates for Maori/Pacific Islanders; similarly, we did not have ethnicity data on the BMDW entries. This information is necessary to allow calculations of donor panel numbers required to allow defined six antigen match rates searches. Related issues which also impact on official panel size are the potential use of one antigen mismatched grafts and the use of placental cord blood progenitor cells which may require a lesser degree of HLA compatibility than adult cells. While this study shows that Pacific Islanders and NZ Maori are disadvantaged with finding donors on existing panels, this is partially offset by the larger family sizes in these racial groups leading to an increased probability of finding a sibling donor. Latest census figures 13 show marked differences in number of children per family between Pacific Islanders, NZ Maori and Caucasians 2.5, 2.1 and 1.9, respectively (P Ͻ 0.001).
The results of this study have policy implications for development of the NZ Bone Marrow Donor Registry. The New Zealand Bone Marrow Donor Registry (NZBMDR) was established in 1997 to facilitate finding donors for New Zealand patients requiring matched unrelated donor (MUD) transplants. Because of the small population of New Zealand (approximately 3.5 million) it was decided that New Zealand Registry be integrated into the Australian Bone Marrow Donor Registry (ABMDR). As the New Zealand population has a significant number of Maori and other Polynesian peoples (Figure 2 ), a policy was established to recruit donors mainly from these ethnic groups giving the ABMDR via NZBMDR a unique population set.
